Validation of Two Screening Tools for Anxiety in Hemodialysis Patients

Background: Symptoms of anxiety are often unrecognized and untreated in dialysis patients. We investigated the diagnostic accuracy of two widely used screening tools for anxiety in hemodialysis patients. Methods: For this cross-sectional validation study, chronic hemodialysis patients from eight dia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of personalized medicine Jg. 12; H. 7; S. 1077
Hauptverfasser: Nadort, Els, van Geenen, Noëlle J. K., Schouten, Robbert W., Boeschoten, Rosa E., Chandie Shaw, Prataap, Vleming, Louis Jean, Schouten, Marcel, Farhat, Karima, Dekker, Friedo W., van Oppen, Patricia, Siegert, Carl E. H., Broekman, Birit F. P.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Basel MDPI AG 30.06.2022
MDPI
Schlagworte:
Accuracy
Anxiety
Anxiety disorders
Clinical outcomes
Comorbidity
Fear & phobias
Hemodialysis
Informed consent
Interviews
Kidney diseases
Medical ethics
Medical residencies
Mental depression
Mortality
Nephrology
Panic attacks
Patients
Post traumatic stress disorder
Precision medicine
Psychiatrists
Self report
Validation studies
Netherlands
ISSN:2075-4426, 2075-4426
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Symptoms of anxiety are often unrecognized and untreated in dialysis patients. We investigated the diagnostic accuracy of two widely used screening tools for anxiety in hemodialysis patients. Methods: For this cross-sectional validation study, chronic hemodialysis patients from eight dialysis centers in the Netherlands were included. The Beck Anxiety Inventory (BAI) and Hospital Anxiety and Depression Scale—Anxiety subscale (HADS-A) were validated by the Mini International Neuropsychiatric Inventory (MINI) diagnostic interview. Receiver operating characteristic curves were used to determine the optimal cut-off values. Results: Of 65 participants, 13 (20%) were diagnosed with one or more anxiety disorders on the MINI, of which 5 were included in the analysis. ROC curves showed a good diagnostic accuracy of the BAI and HADS-A. The optimal cut-off value for the BAI was ≥13 (sensitivity 100%, specificity 85%) and for the HADS-A was ≥10 (sensitivity 80%, specificity 100%). Conclusions: Based on our limited data, both the BAI and the HADS-A seem to be valid screening instruments for anxiety in hemodialysis patients that can be used in routine dialysis care. The HADS-A consists of fewer items and showed fewer false-positive results than the BAI, which might make it more useful in clinical practice.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2075-4426
2075-4426
DOI:10.3390/jpm12071077